Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: A meta analysis

International Journal of Clinical Practice

Volumn 64, Issue 9, 2010, Pages 1239-1244

  Coleman, C I ^a,b   Tuttle, L A ^b   Teevan, C ^b   Baker, W L ^b   White, C M ^a,b   Reinhart, K M ^c  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c WINGATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PLACEBO; TICLOPIDINE;

ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GRAFT THROMBOSIS; HEMODIALYSIS; HUMAN; META ANALYSIS; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; GRAFT OCCLUSION, VASCULAR; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS;

EID: 77954632374     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02329.x     Document Type: Article

References (17)

1. National Kidney Foundation. K/DOQI Clinical practice guidelines and recommendations 2006 updates vascular access. Am J Kidney Dis 2006 48 (Suppl. 1 S176 273.
2. Abdul-Rahman IS, Al-Howaish AK. Warfarin versus aspirin in preventing tunneled hemodialysis catheter thrombosis: a prospective randomized study. Hong Kong J Nephrol 2007 9 : 23 30.
3. Swedberg SH, Brown BG, Sigley R, Wight TN, Gordon D, Nicholls SC. Intimal fibromuscular hyperplasia at the venous anastomosis of PFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment. Circulation 1989 80 : 1726 1736.
4. Osborn G, Escofet X, Da Silva A. Medical adjuvant treatment to increase the patency of arteriovenous fistulae and grafts. Cochrane Database Syst Rev 2008 Issue 4. Art. No.:CK002786. DOI :.
5. Dember LM, Beck GJ, Allon M et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. A randomized controlled trial. JAMA 2008 299 : 2164 2171.
6. Dixon BS, Beck GJ, Vazquez MA et al. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009 360 : 2191 2201.
7. Jadad AR, Moore A, Carroll D et al. Assessing the quality of reports of randomized controlled trials: is blinding necessary? Control Clin Trials 1996 17 : 1 12.
8. Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 188.
9. Trimarchi J, Young P, Forrester M, Schropp J, Pereyra H, Freixas E. Clopidogrel diminishes hemodialysis access graft thrombosis. Nephron Clin Pract 2006 102 : c128 32.
10. Kooistra MP, Van Es A, Marx JJM, Hertsig MLA, Struyvenberg A. Low-dose aspririn does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin. Nephrol Dial Transplant 1994 9 : 1115 1120.
11. Sreedhara R, Himmilfarb J, Lasarus JM, Hakim RM. Anti-platelet therapy in graft thombosis: results of a prospective, randomized, double-blind study. Kindey Int 1994 45 : 1477 1483.
12. Andrassy K, Malluche H, Bornefeld H et al. Prevention of p.o. clotting of av. Cimino fistuae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr 1974 52 : 348 349.
13. Fickerstrand CE, Thompson IW, Burnet ME, Williams P, Anderton JL. Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs 1985 9 : 61 3.
14. Gröntoft KC, Mulec H, Gutierrez A, Olander R. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol 1985 19 : 55 7.
15. Gröntoft KC, Larsson R, Mulec H, Weiss LG, Dickinson JP. Effects of ticlopidine in AV-fistula surgery in uremia. Scand J Urol Nephrol 1998 32 : 276 283.
16. Kaufman JS, O'Connor TZ, Zhang JH et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 2003 14 : 2313 2321.
17. Yevzlin AS, Conley EL, Sanchez RJ, Young HN, Backer BN. Vascular access outcomes and medications use: a USRDS study. Semin Dial 2006 19 : 535 539.